Saturn V Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-982,458	Closed	-$6.96M	–	24
2023 Q3	$6.96M	Buy	982,458 +27,602	+3%	+$195K	2.91%	16
2023 Q2	$6.72M	Sell	954,856 -208,679	-18%	-$1.47M	3.73%	14
2023 Q1	$9.7M	Buy	1,163,535 +823,372	+242%	+$6.87M	7.25%	7
2022 Q4	$3.75M	Buy	+340,163	New	+$3.75M	3.11%	16